Emmenagogues are herbal medicines widely consumed by Thai women without prescription. The purpose of this study is to evaluate the possible toxicity of emmenagogue drugs and their nitrosated products by using human peripheral blood lymphocytes. The blood of ten healthy females between 20-35 years of age was tested with various drug concentrations as well as their nitrosated products. Mitomycin C and aminopyrene were used as positive controls. Chromosome aberration such as gap, break and fragment were obtained in this experiment with no statistically significant differences found between treatment and controls. Cell toxicity manifesting as chromosome contraction occurred when the drug concentration increased 20 fold. The results suggest that 1 in 6 nitrosated products can cause chromatid-type aberration.
INTRODUCTION
Emmenagogue drugs are herbal medicines which people in Thailand can freely buy without prescription. To date, the chemical substances of these drugs have not been shown to induce hereditary mutations in man. These drugs contain many natural medicinal plants such as sovage, cinnamon, mint, clove and zingiber which were shown to cause mutagenicity and toxicity in bacterial and mammalian cells (Unsurungsie et al., 1982; Unsurungsie et al., 1984; Lee et al., 1984; Boontim, 1990) . Chaiyakum et al. (1983) studied the relationship between the emmenagogue drugs and birth defects at Chulalongkorn hospital during 1979 to 1981. They reported that there was a significant (p<0.05) increase in the delivery of malformed babies among mothers who had taken these drugs. Toxicity and mutagenicity of the drugs and their nitrosated products were screened by Ame's Salmonella assays (Kangsdalampai and Rodjanapo, 1988) . They found that nitrosated drugs caused mutagenicity in Salmonella typhimurium. It is known that nitroso compounds, potent carcinogens are formed by the reaction of nitrogencontaining compounds with nitrite in vivo. Drugs contain nitrosable precursors exposing humans to the formation of hazardous substances by drug-nitrite interaction. To establish the safety of drugs, it is necessary to screen out drugs in which interaction with nitrite may give rise to hazardous products. However, to date, there are few reports of drug toxicity.
Results of an international collaborative trial (Ashby et al., 1985) suggest that measurement of chromosomal aberration is an appropriate test to complement bacterial mutagenicity such as Ame's test for predicting the carcinogenic and mutagenic potential of various chemicals. Human blood is a conveniently obtained tissue in which lymphocytes cells can be stimulated to divide in short-term cultures and chromosome aberrations measured after appropriate treatment. In man, chromosomal assays are used as an indicator of risk and also possibly used in establishing a genetically meaningful maximum allowable concentration of compounds. The objective of this study was to evaluate the toxicity and clastogenicity of emmenagogue drugs and their nitrosated products by using human lymphocytes.
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MATERIALS AND METHODS
Preparation of Emmenagogue Drugs
Six popular brands of emmenagogue drugs were bought from drug stores in local market, Chiang Mai province. Each drug was evaporated under vacuum at 45°C until the final concentration of the drug was increased to 20 times. After that, the concentrated drug was diluted with distilled water to 10, 4 and 2 times, respectively.
Drug-Nitrite Interaction
The drug-nitrite interaction procedure has been previously described by Takeda et al. (1982) . Briefly, 100 µl of each drug concentration was previously mixed with 750 µl of 0.2 N HCl and 250 µl of 2 M sodium nitrite in a test tube fitted with a glass stopper then shaken at 37°C for 4 hours. 250 µl of 2 M ammonium sulfate was then added and the tube was allowed to stand for 10 minutes with gentle shaking in an ice bath before testing with lymphocytes culture. Mitomycin C and aminopyrene were used as the positive controls for drugs and nitrosated products, respectively.
Lymphocyte Culture
Venous blood was collected from 10 healthy donors, and coagglulation was inhibited by the addition of heparin. All donors were females between the ages of 20 and 35 were not taking any medication prior to this investigation. Whole-blood cultures were prepared by the addition of 200 µl blood to 3 ml of RPMI 1640 medium containing 20% fetal bovine serum and 1.5 % phytohaemaglutinin M. All cultures were incubated at 37°C for 30 hours before further treatment.
Testing of Lymphocytes
A dose range of the drug was investigated utilizing lymphocyte assays with and without nitrite interaction. One hundred microliters of each drug or nitrosated drug was added to lymphocytes previously cultured for 30 hours (37°C). The culture was then incubated at 37°C for an additional 72 hours. Cocemid was added to the culture prior to harvesting. The cells were collected by centrifugation (10 min; 2000 rpm), hypotonic treatment (0.75 M KCl) was given for 10 minutes at 37°C. Following centrifugation, the swollen cells were fixed in cold fixation reagent (methanol:acetic acid, 3:1). For chromosome aberration analysis, slides were stained with 10% Giemsa solution, pH 6.8 for 30 minutes. The glass slides were scored blind coded and mitotic indices were determined by analysis of 100 well-spread metaphases per slide. The metaphase cells were screened for numerical and structural chromosome aberration, using ISCN (International System for Human Cytogenetic Nomenclature, 1978) . The Mann-Whitney U Test was used to test for statistical significance.
RESULTS
Effect of the Drugs and Nitrosated Drugs on Chromosome Number
The result showed that there was no significant difference in the frequency of polyploidy chromosomes of drug-treated cultures compared to control. Differences the number of frequency of aneuploidy cells in drug-exposed cultures were found compared to the unexposed group, but a dose response relationship was not seen. These results indicated that the drugs and nitrosated drugs did not induce a statistically significant increase in the frequency of cells with aberrations, although aneuploidy and polyploidy were found.
Effect of the Drug and Nitrosated Products on Chromosome Structure
In all cell cultures high drug concentration was demonstrated by a decline in the mitotic indices. We found no a statically significant difference in the frequency of aberration between drug without nitrite interaction and the control groups. Cell toxicity, which caused chromosome contraction was seen in lymphocyte culture treated with Benlo drug when a 20-fold concentration was reached (Fig. 1) . Although, chromatid type aberration such as gaps and breaks were found in lymphocytes treated with all drugs, they did not induce structural chromosome aberration (Table 1, Fig. 2 ). Nitrosated products of Penpark drug at 20-fold concentration caused chromosome aberrations (Table 2) . However, chromatid interchange events were not found in all test cultures with the exception of cultures treated with mitomycin C (Fig. 3) .
DISCUSSION
No clastogenic activity was exhibited by the emmenagogue drug. Chromosome contractions were observed when lymphocyte cultures were treated with Benlo drug in 20-fold concentrations. This result may due to this drugs ability to inhibit spindle fibers. However, culture toxicity occurred without a marked increase in aberration frequency. Statistically-significant differences between the test and control cultures at 0.05 level indicated that at least one kind of nitrosated product was capable of inducing structural chromosome aberration. However, most of types of aberrances seen in cells were gaps and many cytogeneticists have not included them in their analysis (Bragger, 1982) . In 1988, Kangsadalampai and Rodjanapo also reported that genetic damage was found in bacteria after treatment with nitrosated drugs. Aberrations that occurred were mostly of chromatid type. This phenomenon is due to the type of induced DNA lesions which have to pass through an S phase in order to be transformed into aberration. Although, the toxicity of the nitrosated product was very weak, consumers should be careful and aware of the potential hazards of the drug, especially if they are continuously exposed to for such long periods. 
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